Any views expressed within media held on this service are those of the contributors, should not be taken as approved or endorsed by the University, and do not necessarily reflect the views of the University in respect of any particular issue.

One year on…

Last week marked one year mark since the first pandemic lockdown started and many of us took part in the one minute’s silence held on 23rd March to pay our sympathies and respects to the more than 126,000 individuals who have been lost to our communities. Looking forward, there is a sense of optimism on the horizon now that the vaccination programmes are being rolled out with huge success. Our healthcare teams around the country have risen to an unprecedented challenge and made massive contributions in response of the pandemic.

Our staff are still making fantastic efforts to deliver the best in health and social care research despite challenging circumstances, and our University colleagues  continue to deliver education to the student body.

With pride we can reflect on how our researchers are leading work on disease susceptibility, treatments, the effectiveness of vaccines and other critical clinical aspects. Having been well supported by regulatory, funding and R&D teams.

Many personal and professional battles have been fought during the challenges of the past year and these make all of the achievements attained even more remarkable. Well done, we’re doing it. There is light at the end of the tunnel, and as the spring months extend into summer we can hopefully get back to enjoying what we did before.

For us this will be maintaining a sense of community and support for our clinical research teams, delivering training and education in both online and face-2-face formats and continuing to improve our learning and development offering so that we can respond to these types of events together.

Keep well, stay safe 🌈

Webinar 8 – Monitoring during a Pandemic

Webinar 8 brings us an update from Elizabeth Craig, Senior Clinical Trials Monitor in ACCORD. Here she discusses Monitoring during a Pandemic and if you maintain Sponsor oversight without leaving home?

Taking us through the events of last year, Liz reflects on how the pandemic has impacted her team and the service they provide. She will present some of the 2020 metrics along with what they have developed process wise to continue risk based monitoring remotely across the portfolio.

Liz will pay particular attention to the pros and cons and highlight some of the processes the team will actually keep in place post pandemic because there are definitely some changes which will stick around long term.

 

Webinar 7 – Medicines Regulation

One year ago this week, experts at the Western General Hospital’s Regional Infectious Diseases Unit (RIDU) became the first to care for a patient who had tested positive for COVID-19 in Scotland.  ‘They were certain that “life as we knew it would change” in the instant they received the emergency call’, they weren’t wrong!

Together we unite

Fast forward to February 2021, and Professor Stuart Ralston joins us for the Research during a Pandemic webinar series where he talks about his role as Chair of the Commission for Human Medicines, and how we have got to where we are with the Covid-19 vaccines as well as what he anticipates in the future.

Covid Vaccine
Covid Vaccine
css.php

Report this page

To report inappropriate content on this page, please use the form below. Upon receiving your report, we will be in touch as per the Take Down Policy of the service.

Please note that personal data collected through this form is used and stored for the purposes of processing this report and communication with you.

If you are unable to report a concern about content via this form please contact the Service Owner.

Please enter an email address you wish to be contacted on. Please describe the unacceptable content in sufficient detail to allow us to locate it, and why you consider it to be unacceptable.
By submitting this report, you accept that it is accurate and that fraudulent or nuisance complaints may result in action by the University.

  Cancel